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a b s t r a c t
Idiopathic intracranial hypertension (IIH) is a relatively uncommon disorder characterised
by raised intracranial pressure without an established pathogenesis. Diagnosis of IIH
requires the demonstration of symptoms and signs referable only to elevated intracranial
pressure; cerebrospinal ﬂuid (CSF) opening pressure >25 cm H2O measured in the lateral
decubitus position; normal CSF composition; and no evidence for an underlying structural
cause demonstrated by using MRI or contrast-enhanced CT scan for typical patients and MRI
and MR venography for atypical patients such as man, children and those with low body
mass index. We present a 38-year old primigravid renal transplant patient at 7 weeks of
gestation who presented with 2 weeks of intense, throbbing, holocranial headache, nausea,
vomiting, photophobia, diplopia and progressive visual loss. When medical treatment fails
and/or not appropriate to use due to the reported of teratogenic risks in pregnant women,
surgical interventions gain importance. In this particular patient, venticuloperitoneal shunt
was chosen as the CSF diversion technique. In this case report indications, contraindications
in addition to outcomes regarding headache, vision loss and the resolution of papilloedema
of the present surgery options for IIH are discussed.
© 2018 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Idiopathic intracranial hypertension (IIH) is a relatively
uncommon disorder characterised by raised intracranial* Corresponding author.
E-mail address: ebrudogan@akdeniz.edu.tr (E.A. Doğan).
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0028-3843/© 2018 Polish Neurological Society. Published by Elsevier Spressure without an established pathogenesis. Diagnosis of
IIH requires the demonstration of (1) symptoms and signs
referable only to elevated intracranial pressure; (2) cerebrospi-
nal ﬂuid (CSF) opening pressure >25 cm H2O measured in the
lateral decubitus position; (3) normal CSF composition; and (4)
no evidence for an underlying structural cause demonstratedp. z o.o. All rights reserved.
Fig. 1 – (a) Cranial MRI. (b) MR venography.
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and MRI and MR venography for atypical patients such as man,
children and those with low body mass index (BMI) [1].
Headache is the most prominent feature of the disease.
Patients describe different patterns of headaches; pressure-
like, holocranial, frontal or retro-orbital which typically
worsen with Valsalva-type manoeuvres. Posture-related uni-
lateral or bilateral transient visual obscurations are usually
reported. Pulsatile tinnitus, nausea, vomiting, photophobia
and diplopia are amongst the other most encountered
complaints [2].
We present a pregnant renal transplant recipient which
complicated with IIH at the seventh week of gestation.
2. Case report
A 38-year old primigravid woman at 7 weeks of gestation
presented with 2 weeks of intense, throbbing, holocranial
headache, nausea, vomiting, photophobia, diplopia, progres-
sive visual loss and transient total visual obscurations
precipated by changes in posture that last several seconds.
Her past medical history was remarkable for an end-stage
kidney disease in the course of reﬂux nephropathy which
progressed to kidney transplant from a cadaveric donor nine
years ago. The immunsupressive treatment included tacroli-
mus, azathioprine and prednisone. The allograft function and
evolution were good (creatinine = 1.1 mg/dL). On examination
she was normotensive and her BMI was 25 kg/m2. Neurologic
examination revealed left abducens nerve palsy, bilateral
papilledema with retinal haemorrhages.
In view of the possibility of an intracranial mass lesion,
cranial MRI and MR venography were performed which
evidenced no structural alterations (Fig. 1a and b). Ophthalmo-
logic examination revealed a visual acuity of 20/20 with normal
anterior segment ﬁndings of both eyes. The central 30-2 visual
ﬁeld test demonstrated an enlarged blind spot and retinal
haemorrhages with optic disc swelling in both eyes. A diagnostic
lumbar puncture (LP) was performed. The opening pressure
which was recorded with a simple column manometer was
340 mm H2O. Cultures and investigations for toxoplasmosis,
tuberculosis, syphilis, neurocysticercosis, cryptococcosis, and
cytomegalovirus inthe CSF were also planned in case of a central
infection associated with chronic immunsuppression were all
negative. Acetolazamide could not be initiated due to slightly
elevated serum creatinine levels and ongoing pregnancy. She
underwent repeated lumbar punctures, however CSF pressure
continued to increase and her vision deteriorated. With the
concern of ongoing visual loss besides intractable headache, the
patient was consulted with the neurosurgery department. A
ventriculoperitoneal (VP)shunt wasplacedonthe14thday ofher
referral. She experienced instant relief, remained asymptomatic
and was discharged the following day. Pre- and postoperative
photographs of the fundus are illustrated (Fig. 2a and b).
Unfortunately on the course of this process the patient
aborted at the tenth week of gestation spontaneously after the
insertion of VP shunt. The healing process accelerated
signiﬁcantly after the miscarriage. Considering the headache
and vision, she is still asymptomatic after 3 years of the
diagnosis of IIH.3. Discussion
The incidence of IIH in renal transplant patients is unknown
and the pathogenesis still remains unclear [1,3]. Proposed
mechanisms are parenchymal oedema, increased cerebral
blood volume, excessive CSF production, venous outﬂow
obstruction and compromised CSF resorption. Possible contri-
bution of inﬂammatory factors is also being discussed in very
recent studies. One of these is a study in which cytokine levels
and oligoclonal bands have been found to be correlated with
IIH and loss of vision. Results of this prospectively designed
study emphasizes the immunologic background of IIH [4].
Previously, it was believed that IIH was triggered or
exacerbated by pregnancy. However, IIH occurs in pregnancies
Fig. 2 – (a–b) Pre- and postoperative fundus photographs.
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association of pregnancy with PTC is probably only a measure
of the fact that IIH affects women of child-bearing age [1]. We
presented an unusual case of adult renal transplant recipient
with IIH that was managed successfully with VP shunt. In this
particular group of patients, early diagnosis and multidisci-
plinary care can salvage the patient from the risk of blindness
associated with IIH.
Although no consensus exists on the best management
strategy for IIH, effectiveness of acetolazamide, topiramate and
octreotide have been assessedin severalstudies.Octreotide has
been used in an uncontrolled open-label prospective study and
the authors have reported that octreotide might be a promising
therapeutic option for IIH. However, they have also expressed
their questions which have remained to be answered in further
clinical trials including the optimal treatment duration, the
efﬁcacy and safety of this drug in IIH [5].
It is well known that there is a direct link between obesity
and IIH and that weight loss plays an important role in the
management. In their study Altıokka-Uzun et al. have
explained this link with a different aspect. Obesity is regarded
as a proinﬂammatory state and is associated with increased
expression of a number of adipokines and cytokines. Theyhave noted that oligoclonal bands are also obtained in
overweight individuals which is called ‘‘rapid-onset obesity
with hypothalamic dysfunction, hypoventilation and auto-
nomic dysregulation syndrome’’ [4].
However, despite loss of weight and best medical treatment
strategies, surgical interventions become inevitable for
patients with progressive visual loss or intractable headache.
Procedures that are available include the placement of a
lumboperitoneal (LP) shunt, VP shunt, optic nerve sheath
fenestration (ONSF) or the insertion of a dural venous sinus
stent [6,7]. The choice of decision depends on local expertise
and the biases of the treating physicians.
The case presented here had an absolute indication for
surgery due to the severe loss of vision and intractable
headache. ONSF is a surgical technique in which optic nerve
is exposed to several slits in dura and arachnoid mater [8].
However ONSF was not an appropriate choice for our patient as
although might be effective in reversing vision loss, it does not
provide any beneﬁt for headache [9]. As intractable headache
was amongst the major problems this surgical procedure was
not considered as an option in our case. Other techniques which
are evaluated under the heading of cerebrospinal ﬂuid
diversion techniques include lumboperitoneal (LP) shunt,
ventriculoatrial (VA) shunt and VP shunt. Although investiga-
tors conclude that data is inconclusive to suggest or refuse any
treatment modalities, it is reported that LP shunting is
associated with higher complications when compared to VP
shunting in addition to shorter survival rates [9]. On the other
hand VA shunt is a technique which has been popular in the
early 1950s [10]. However after experiencing serious complica-
tions and intraoperative difﬁculties VA shunts were generally
avoided and consequently in the late 1970s, VA shunts became
outdated following the introduction of VP shunt [11].
The literature regarding CSF diversion techniques are poor
and inconclusive. There is only one study in the literature in
which LP and VP shunt have been compared on the same
symptoms management. In this study Tarnaris et al. have
investigated the outcomes in patients with intracranial
hypertension based on cerebrospinal ﬂuid diversion site
[12]. According to their results based on 34 patients, they
have concluded that predicting which patients will improve is
not possible and that the inﬂuence of site diversion is not
critical but patients with VP shunt have less complications and
revisions than those receiving a LP shunt.
Sinus stenting is an another efﬁcient treatment option with
low complication rates for cases with radiologically conﬁrmed
sinus venous thrombosis [13]. The only contraindication for
transverse sinus stenting is dural venous thrombosis [13,14].
However no evidence for sinus venous thrombosis was evident
in our case (Fig. 1b). Therefore VP shunt was the choice of
treatment in our patient. Although placement of VP shunt in
this patient population can often be difﬁcult due to the small
size of the ventricular system, intraoperative adjuvant
techniques can be used to improve the accuracy and safety
of VP shunt particularly for these patients. Various intraop-
erative adjuvant techniques have been employed in addres-
sing the challenges of accurately cannulating the undersized
ventricular system in IIH. These include the use of ultrasound
guidance, neuronavigation, neuroendoscopy and intraopera-
tive computed tomography (CT) [15]. In our case we used the
Table 1 – Surgical treatment options in PTC.
Major indication(s) Headache outcome Visual outcome Complications
ONSFa Visual disturbances Not indicated
for headache
31–72% Infection, transient or permanent
diplopia, transient or permanent loss
of vision, ischaemic optic neuropathy
LP shunt Headache and visual
disturbances
71% 42% resolution in papilloedema
(15.9–22.7%)
Excessively low CSF pressure;
obstruction of the catheter, infection
VP shuntb Headache and visual
disturbances
60% 40% resolution in papilloedema
(100%)
Excessively low CSF pressure;





88% 87–91% resolution in
papilloedema (91–97%)
Efﬁcient technique with very low
complication rates
a Optic nerve sheath fenestration.
b Ventriculoperitoneal shunt; revision rates are lower when compared to lumboperitoneal shunt.
c Indicated in cases those with radiologically confirmed sinus venous thrombosis only; contraindicated in dural venous thrombosis.
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catheter and conﬁrmed the appropriate location on postoper-
ative CT.
It is recommended that pregnant patients with IIH should
be managed in the same way as any other patient with IIH.
Treatment should based on management of preservation of
vision and resolution of headache. Medical therapy includes
carbonic anhydrase inhibitors (acetolazamide/topiramate),
weight control, nonketotic diet, serial lumbar punctures,
diuretics and analgesics [16]. Acetolazamide has double
action, it works as a diuretic and it has been shown that
CSF production reduces by 50% after acetalazomide treatment.
However when medical treatment fails and/or not appropriate
to use due to the reported of teratogenic risks in pregnant
women, surgical interventions gain importance. Indications,
contraindications in addition to outcomes regarding head-
ache, vision loss and the resolution of papilloedema of the
present surgery options for IIH was outlined in Table 1 [9].
Pregnancy is not considered to be a risk factor for IIH,
however in pregnant patients with co-existing conditions such
as being a recipient of renal transplant, IHH could be more
prevalent [17–21]. Therefore, there should be a high index of
suspicion for IHH in patients with persistent headaches and
rapid visual loss. In refractory cases particularly in patients
with co-existing conditions CSF diversion techniques could be
the only exit to salvage vision and resolve the symptoms.
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